Andy Shih works closely with members of Autism Speaks’ Board, Scientific Advisory Committee, senior staff and volunteer leadership to develop and implement the organization’s research program. He oversees the public health portfolio, which includes Autism Speaks’ Global Autism Public Health Initiative, an international advocacy and development effort currently active in over 70 countries that integrates awareness, research, and service development. Dr. Shih and his team serve as technical advisor to ministries and other government agencies by facilitating multi-stakeholder collaboration and sourcing needed content expertise and other technical resources with the goal of delivering community-based feasible, cost-effective and sustainable solutions. His research background includes published studies in gene identification and characterization, virus-cell interaction, and cell-cycle regulation. He was instrumental in the cloning of a family of small GTPases involved in cell-cycle control and nuclear transport, and holds three patents on nucleic acids-based diagnostics and therapeutics. Prior to focusing on Autism Speaks’ public health/international development efforts, Dr. Shih oversaw the organization’s investments in genetics, environmental sciences, epidemiology and assistive technologies.